Radiopharm Theranostics Ltd (RADX) Stock Price, Quote, News & History

RADXNASDAQ
$4.63
0.030.65%
At close: May 22, 5:00 PM EST
$4.55
-0.0804-1.74%
After Hours: May 22, 7:36 PM EST
Loading...

Key Statistics

Open
$4.65
Close
$4.63
Volume / Avg.
15.97K / 156.73K
Day Range
$4.51 - $4.65
52 Wk Range
3.62 - 16.25
Market Cap
$35.40M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
52
Short Interest
0.57%
Days to Cover
1.24

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-
Investing Cash Flow (TTM)
1.77M
Financing Cash Flow (TTM)
45.43M
Free Cash Flow (TTM)
-36.65M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
10.56M

Analyst Trends and Forecast

1
Nov 25
1
Dec 25
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$14.68M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
14.01
PB Ratio (TTM)
1.14
Earnings Yield % (TTM)
-81.79%
Earnings Yield % (FWD)
-23.61%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$4.04

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
$0
LT Debt Repayment (TTM)
-$1.90M
Total Cash
$36.44M
Debt to Equity
-
Issuance of Debt (TTM)
-$1.90M
Repayment of Debt (TTM)
-$1.90M

Key Statistics

Open
$4.65
Close
$4.63
Volume / Avg.
15.97K / 156.73K
Day Range
$4.51 - $4.65
52 Wk Range
3.62 - 16.25
Market Cap
$35.40M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
52
Short Interest
0.57%
Days to Cover
1.24

About

Sector
Health Care
Industry
Biotechnology
Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pr...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Radiopharm Theranostics (RADX) stock?

A

You can purchase shares of Radiopharm Theranostics (NASDAQ:RADX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Radiopharm Theranostics (RADX) competitors?

A

There are no as such competitors for Radiopharm Theranostics.

Q

What is the forecast, or price target, for Radiopharm Theranostics (RADX) stock?

A

Radiopharm Theranostics has a consensus price target of $15.33.

Q

What is the current price for Radiopharm Theranostics (RADX)?

A

The stock price for Radiopharm Theranostics (NASDAQ: RADX) is $4.5496 last updated May 22, 2026 at 7:36 PM EDT.

Q

Does Radiopharm Theranostics (RADX) pay a dividend?

A

There are no upcoming dividends for Radiopharm Theranostics.

Q

When is Radiopharm Theranostics (NASDAQ:RADX) reporting earnings?

A

Radiopharm Theranostics does not have any upcoming earnings scheduled.

Q

Is Radiopharm Theranostics (RADX) going to split?

A

There is no upcoming split for Radiopharm Theranostics.

Q

What sector and industry does Radiopharm Theranostics (RADX) operate in?

A

Radiopharm Theranostics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.